These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 27915969)

  • 1. Anoikis and EMT: Lethal "Liaisons" during Cancer Progression.
    Cao Z; Livas T; Kyprianou N
    Crit Rev Oncog; 2016; 21(3-4):155-168. PubMed ID: 27915969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting anoikis resistance in prostate cancer metastasis.
    Sakamoto S; Kyprianou N
    Mol Aspects Med; 2010 Apr; 31(2):205-14. PubMed ID: 20153362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis.
    Chaotham C; Pongrakhananon V; Sritularak B; Chanvorachote P
    Anticancer Res; 2014 Apr; 34(4):1931-8. PubMed ID: 24692728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling Prostate Cancer Therapeutic Resistance.
    Wade CA; Kyprianou N
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells.
    Wudtiwai B; Pitchakarn P; Banjerdpongchai R
    Toxicol In Vitro; 2018 Dec; 53():222-232. PubMed ID: 30195041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anoikis molecular pathways and its role in cancer progression.
    Paoli P; Giannoni E; Chiarugi P
    Biochim Biophys Acta; 2013 Dec; 1833(12):3481-3498. PubMed ID: 23830918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel anti-cancer agent, FPDHP, induces anoikis in various human cancer cells through activation of calpain, and downregulation of anoikis-related molecules.
    Kim SG; Yooun JH; Kim DE; Lee ES; Kwon TK; Kim S; Park JW
    J Cell Biochem; 2018 Jul; 119(7):5620-5631. PubMed ID: 29388704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
    Du B; Shim JS
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells.
    Busaranon K; Plaimee P; Sritularak B; Chanvorachote P
    J Nat Med; 2016 Jan; 70(1):18-27. PubMed ID: 26384689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goniothalamin Induces Necroptosis and Anoikis in Human Invasive Breast Cancer MDA-MB-231 Cells.
    Khaw-On P; Pompimon W; Banjerdpongchai R
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
    Wang Y; Wang H; Zhou R; Zhong W; Lu S; Ma Z; Chai Y
    Anticancer Drugs; 2017 Jul; 28(6):581-587. PubMed ID: 28379900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anoikis in phenotypic reprogramming of the prostate tumor microenvironment.
    Nepali PR; Kyprianou N
    Front Endocrinol (Lausanne); 2023; 14():1160267. PubMed ID: 37091854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).
    Huang RY; Wong MK; Tan TZ; Kuay KT; Ng AH; Chung VY; Chu YS; Matsumura N; Lai HC; Lee YF; Sim WJ; Chai C; Pietschmann E; Mori S; Low JJ; Choolani M; Thiery JP
    Cell Death Dis; 2013 Nov; 4(11):e915. PubMed ID: 24201814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
    Garg M
    Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells.
    Unahabhokha T; Chanvorachote P; Pongrakhananon V
    Tumour Biol; 2016 Jul; 37(7):8633-41. PubMed ID: 26733180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis.
    Frisch SM; Schaller M; Cieply B
    J Cell Sci; 2013 Jan; 126(Pt 1):21-9. PubMed ID: 23516327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoskeleton targeting value in prostate cancer treatment.
    Martin SK; Kamelgarn M; Kyprianou N
    Am J Clin Exp Urol; 2014; 2(1):15-26. PubMed ID: 25374905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of miR-200 family in metastasis: focus on EMT, CSCs, angiogenesis, and anoikis.
    Babaei G; Raei N; Toofani Milani A; Gholizadeh-Ghaleh Aziz S; Pourjabbar N; Geravand F
    Mol Biol Rep; 2021 Oct; 48(10):6935-6947. PubMed ID: 34510322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.